EFTA Document EFTA01492867

FINANCIAL TRUST COMPANY INC ACCT. For the Period 3/1/12 to 3/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized Gain Loss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gam/Loss Est. Annual Inc Original Cost Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 15.98 126.00 91.64 16,535.000 264,229.30 251,475.52 12,753.78 BIOGEN IDEC INC 09062X-10-3 BIIB DB DONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 1 3%CPN 30% CAP INITIAL LEVEL-07,15,11 MS 21 09 2515A1-A7-6 2,095 000 1,000.000 000 263,970.00 250,454.95 13,515.05 916,400.00 1,000,000.00 (83,600.00) P DOLLAR GENERAL CORP 256677-10-5 DG 46.20 MOO P DUNIUN BRANDS GROUP INC 265504-10-0 DNKN 30.06 0.00 1.99% HSBC MARKET PLUS SPX 06117/13 72% KO BARRIER- 096CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 102.72 5,000,000.000 5,138000.00 5,000,000.00 138.000.00 4042K1-X0-1 JP Morgan Account Page 5 of 32 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00015686 SDNY_GM_00284884 EFTA01492867